Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FATE | AMGN | GILD | VRTX | REGN |
| Company | Fate Therapeutics | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.88 | 265.72 | 65.50 | 393.52 | 881.72 |
| High | 3.95 | 271.68 | 66.35 | 399.68 | 887.48 |
| Low | 3.74 | 265.72 | 64.63 | 393.49 | 875.23 |
| Last | 3.79 | 271.03 | 65.67 | 398.81 | 885.01 |
| Change | -0.08 | +1.65 | +0.40 | +1.11 | -5.67 |
| % Change | -2.07% | +0.61% | +0.61% | +0.28% | -0.64% |
| Volume | 1,643,246 | 713,817 | 7,286,694 | 262,995 | 252,667 |
| 20-Day Average Volume | 2,203,171 | 2,066,926 | 6,773,638 | 921,673 | 443,478 |
| Previous Close | 3.87 | 269.38 | 65.27 | 397.70 | 890.68 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.68 | 269.99 | 68.30 | 401.37 | 918.50 |
| 20-Day Raw Stochastic | 1.94% | 40.81% | 9.84% | 27.33% | 7.49% |
| 20-Day Relative Strength | 26.95% | 45.67% | 29.53% | 44.17% | 32.89% |
| Weighted Alpha | -60.01 | +9.55 | -23.40 | +15.52 | +9.67 |
| Today's Opinion | 8% Sell | 56% Sell | 100% Sell | 8% Buy | 8% Sell |
| Previous Opinion | 8% Sell | 72% Sell | 100% Sell | 8% Buy | 8% Buy |
| Last Month's Opinion | 80% Buy | 40% Buy | 88% Sell | 56% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -20.46% since 04/19/24 | +0.46% since 04/19/24 | -1.92% since 04/19/24 | +1.28% since 04/19/24 | -1.62% since 04/19/24 |
| Low | 3.74 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 393.00 on 04/25/24 | 875.22 on 04/26/24 |
| High | 5.02 on 04/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 | 915.70 on 04/24/24 |
| 1-Month | |||||
| %Chg | -44.46% since 03/26/24 | -4.12% since 03/26/24 | -9.58% since 03/26/24 | -4.57% since 03/26/24 | -8.43% since 03/26/24 |
| Low | 3.74 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 7.65 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -16.45% since 01/26/24 | -13.35% since 01/26/24 | -17.66% since 01/26/24 | -7.17% since 01/26/24 | -6.14% since 01/26/24 |
| Low | 3.74 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 8.83 on 03/07/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +117.71% since 10/26/23 | +0.17% since 10/26/23 | -16.59% since 10/26/23 | +10.53% since 10/26/23 | +11.40% since 10/26/23 |
| Low | 1.63 on 10/30/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 8.83 on 03/07/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 440,472 | 144,488,960 | 81,266,176 | 102,789,152 | 97,762,816 |
| Shares Outstanding, K | 113,817 | 536,376 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 63,530,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -160,930,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 1,680,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | -44,120,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 1.66 | 0.58 | 0.19 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 02/26/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 29.82 | 24.12 |